Physician profile
Yang Liu
NPI 1285079988
$369.29
in general payments reported to CMS, 2019-2025
9 companies · $45.22 in 2025
The $45.22 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $118 · 2021: $27.84 · 2022: $139 · 2024: $39.28 · 2025: $45.22.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $84.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $84.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $120.00 | 2022 | |
| Foundation Medicine, INC. | $118.28 | 2019 | |
| Novartis Pharmaceuticals Corporation | $51.42 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $34.59 | 2021-2022 | |
| Pharmaessentia USA Corporation | $18.30 | 2024 | Besremi |
| Stemline Therapeutics INC. | $14.78 | 2025 | Orserdu |
| Gilead Sciences, INC. | $11.92 | 2021 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yang Liu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.